Search

Your search keyword '"Alekseev B.Y."' showing total 1 results
Start Over Author "Alekseev B.Y." Topic maxima & minima
1 results on '"Alekseev B.Y."'

1. 662P Pembrolizumab (pembro) monotherapy as first-line therapy in advanced non–clear cell renal cell carcinoma (nccRCC): Results after a minimum of 34 months of follow-up from KEYNOTE-427 cohort B.

Author

Lee, J-L., McDermott, D.F., Ziobro, M., Suarez, C., Langiewicz, P., Matveev, V.B., Wiechno, P., Gafanov, R., Tomczak, P., Pouliot, F., Donskov, F., Alekseev, B.Y., Shin, S.J., Bjarnason, G.A., Castellano, D., Liu, H., Burgents, J., Rodriguez-Lopez, K., and Atkins, M.B.

Subjects
*RENAL cell carcinoma, *PEMBROLIZUMAB, *MAXIMA & minima
Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results